Collins S, Daniel K W, Rohlfs E M
Department of Psychiatry and Behavioral Sciences, and The Sarah W. Stedman Center for Nutritional Studies, Duke University Medical Center, Durham, North Carolina 27710, USA.
Int J Obes Relat Metab Disord. 1999 Jul;23(7):669-77. doi: 10.1038/sj.ijo.0800894.
To determine whether the dramatic reduction in expression and functional activity of the beta3-adrenergic receptor (AR) and beta1AR subtypes originally observed in adipose tissue of the C57BL/6J Lep(ob)/Lep(ob) ('obese') mouse are general features of all models of obesity, and whether obesity-related differences in betaAR subtype expression occur between adipose depots.
Survey of adipose tissue betaAR expression from four mouse models of congenital obesity: the 'obese' mouse (C57BL/6J Lep(ob)/Lep(ob)), the 'diabetic' mouse (C57BL/KsJ LepRdb/LepRdb), the 'tubby' mouse (C57BL/6J tub/tub) and the 'fat' mouse (C57BL/KsJ Cpe(fat)/Cpe(fat)), and in a model of high-fat diet-induced obesity in C57BL/6J mice.
Expression of the betaAR subtypes was measured by Northern blot hybridization in white and brown adipose depots.
In the severely obese Lep(ob) and LepRdb mice, mRNA concentrations of beta3AR and beta1AR in white adipose tissue (WAT) were decreased by > 99% and by > 70%, respectively. More modest effects on beta3AR expression were observed in brown adipose tissue (BAT, decreased by 20 - 30%). In less severe forms of obesity, as found in the tubby and carboxypeptidase (Cpe)fat mice, and in diet-induced obese B6 mice, beta3AR expression was decreased in WAT by up to 90%, with more modest decreases in interscapular BAT (IBAT). Changes in beta1AR mRNA concentrations were more variable. Beta2AR mRNA levels did not differ in most cases, with the exception that there was a 3-5-fold increase in BAT for both Lep(ob) and LepRdb mice.
Impaired expression of adipocyte betaAR subtypes is a general feature of both genetic and dietary obesity in mice. The degree of obesity is correlated with the extent of loss of beta3AR and beta1AR expression in WAT. The distinct endocrine abnormalities associated with these obesity models may be responsible for the degree of impaired adipocyte betaAR expression.
确定最初在C57BL/6J Lep(ob)/Lep(ob)(“肥胖”)小鼠脂肪组织中观察到的β3 - 肾上腺素能受体(AR)和β1AR亚型的表达及功能活性的显著降低是否为所有肥胖模型的普遍特征,以及脂肪组织库之间是否存在与肥胖相关的βAR亚型表达差异。
对四种先天性肥胖小鼠模型的脂肪组织βAR表达进行调查:“肥胖”小鼠(C57BL/6J Lep(ob)/Lep(ob))、“糖尿病”小鼠(C57BL/KsJ LepRdb/LepRdb)、“矮胖”小鼠(C57BL/6J tub/tub)和“肥胖”小鼠(C57BL/KsJ Cpe(fat)/Cpe(fat)),以及C57BL/6J小鼠高脂饮食诱导肥胖模型。
通过Northern印迹杂交法测量白色和棕色脂肪组织库中βAR亚型的表达。
在严重肥胖的Lep(ob)和LepRdb小鼠中,白色脂肪组织(WAT)中β3AR和β1AR的mRNA浓度分别降低了>99%和>70%。在棕色脂肪组织(BAT)中观察到对β3AR表达的影响较小(降低20 - 30%)。在较轻度的肥胖形式中,如在矮胖和羧肽酶(Cpe)肥胖小鼠以及饮食诱导肥胖的B6小鼠中,WAT中β3AR表达降低高达90%,肩胛间BAT(IBAT)中的降低幅度较小。β1AR mRNA浓度的变化更具变异性。在大多数情况下,β2AR mRNA水平没有差异,但Lep(ob)和LepRdb小鼠的BAT中β2AR mRNA水平均有3 - 5倍的增加。
脂肪细胞βAR亚型表达受损是小鼠遗传性和饮食性肥胖的普遍特征。肥胖程度与WAT中β3AR和β1AR表达丧失的程度相关。与这些肥胖模型相关的明显内分泌异常可能是脂肪细胞βAR表达受损程度的原因。